Zobrazeno 1 - 10
of 50 787
pro vyhledávání: '"bcr-abl"'
Autor:
Wang S; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China., Chen J; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China., Hou R; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China., Xiong Y; Tianjin Chempharmatech Co., Ltd, B5-4th, Tianda-tech Park, No 80, The 4th Avenue, TEDA, 300000, Tianjin, China., Shi H; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China., Chen Z; St. John's University, 8000 Utopia Parkway, Queens, NY, 11439, United States., Li J; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China. Electronic address: lijiazhong@lzu.edu.cn., Wang X; School of Pharmacy, Lanzhou University, 199 West Donggang Rd., 730000, Lanzhou, China. Electronic address: wx@lzu.edu.cn.
Publikováno v:
Chemico-biological interactions [Chem Biol Interact] 2024 Nov 01; Vol. 403, pp. 111248. Date of Electronic Publication: 2024 Sep 25.
Autor:
Rocha KML; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil., Nascimento ÉCM; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.; Computational Chemistry Laboratory, Institute of Chemistry, University of Brasília, Brasília 70910-900, DF, Brazil., de Jesus RCC; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil., Martins JBL; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.; Computational Chemistry Laboratory, Institute of Chemistry, University of Brasília, Brasília 70910-900, DF, Brazil.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2024 Sep 08; Vol. 29 (17). Date of Electronic Publication: 2024 Sep 08.
Autor:
Innes AJ; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom. a.innes@imperial.ac.uk.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom. a.innes@imperial.ac.uk., Hayden C; North West London Pathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Orovboni V; North West London Pathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Claudiani S; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Fernando F; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Khan A; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Rees D; Medical School, Faculty of Medicine, Imperial College London, London, United Kingdom., Byrne J; Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Francis S; Department of haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Copland M; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Horne G; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Raghavan M; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Arnold C; Department of Haematology, Belfast City Hospital, Belfast, United Kingdom., Collins A; Department of Haematology, Norfolk and Norwich University Hospital, Norwich, United Kingdom., Cranfield T; Department of Haematology, Queen Alexandra Hospital, Portsmouth, United Kingdom., Cunningham N; Department of Haematology, Belfast City Hospital, Belfast, United Kingdom., Danga A; Department of Haematology, The Hillingdon Hospital, London, United Kingdom., Forsyth P; Department of Haematology, Raigmore Hospital, NHS Highland, Inverness, United Kingdom., Frewin R; Department of Haematology, Gloucestershire Royal Hospital, Gloucester, United Kingdom., Garland P; Department of Haematology, Princess Royal University Hospital, London, United Kingdom., Hannah G; Department of Haematology, Kings College Hospital, London, United Kingdom., Avenoso D; Department of Haematology, Kings College Hospital, London, United Kingdom., Hassan S; Department of Haematology, Queen's Hospital, Romford, United Kingdom., Huntly BJP; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Husain J; Department of Haematology, Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, United Kingdom., Makkuni S; Department of Haematology, Mid and South Essex NHS Foundation Trust, Basildon, United Kingdom., Rothwell K; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Basildon, United Kingdom., Khorashad J; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Haemato-oncology Molecular Diagnostic Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom., Apperley JF; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Milojkovic D; Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Publikováno v:
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2443-2455. Date of Electronic Publication: 2024 Sep 17.
Autor:
Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2191-2212. Date of Electronic Publication: 2024 Aug 02.
Autor:
Zeng C; Guangzhou First People's Hospital, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510700, China. chengwuzeng@gzhmu.edu.cn.; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China. chengwuzeng@gzhmu.edu.cn., Nie D; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China.; Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China., Wang X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Zhong S; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Zeng X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Liu X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Qiu K; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Peng X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Zhang W; Guangdong Key Laboratory of Bioactive Drug Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, 510006, China., Chen S; Department of Hematology, Department of clinical laboratory, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Zha X; Department of Hematology, Department of clinical laboratory, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Chen C; Guangzhou First People's Hospital, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510700, China. cuntechen@163.com., Chen Z; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA. zhenhchen@coh.org., Wang W; Guangdong Key Laboratory of Bioactive Drug Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, 510006, China. wangweizhang@gdpu.edu.cn., Li Y; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China. yangqiuli@hotmail.com.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Oct 28; Vol. 23 (1), pp. 240. Date of Electronic Publication: 2024 Oct 28.
Autor:
Haddad FG; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Nasr L; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Dellasala S; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Cortes J; Georgia Cancer Center, Augusta University, Augusta, Georgia, USA., Nicolini FE; Department of Clinical Hematology and INSERM U1052, CRCL, Centre Leon Bérard, Lyon, France., Issa GC; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2024 Oct 01; Vol. 130 (19), pp. 3344-3352. Date of Electronic Publication: 2024 May 28.
Autor:
Abruzzese E; From the Department of Hematology, S. Eugenio Hospital, Tor Vergata University, Azienda Sanitaria Locale Roma 2, Rome.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Sep 12; Vol. 391 (10), pp. 955-957.
Autor:
Qi S; Department of Oncology, Shijiazhuang Traditional Chinese Medicine Hospital, ShiJiaZhuang, HeBei, China., Huang J; Department of Pathology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China., Long R; Digestive Endoscopy Department, Hebei Province Hospital of Traditional Chinese Medicine, Hebei Key Laboratory of Turbidity Toxin Syndrome, ShiJiaZhuang, HeBei, China.
Publikováno v:
Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2024 Sep; Vol. 37 (5), pp. 1019-1025.
Autor:
Combes FP; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. francois_pierre.combes@novartis.com., Sy SKB; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Li YF; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Lorenzo S; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Dasgupta K; Novartis Healthcare Pvt Ltd, Hyderabad, India., Kapoor S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Hoch M; Novartis Institute of Biomedical Research, Basel, Switzerland., Ho YY; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Sep; Vol. 63 (9), pp. 1301-1312. Date of Electronic Publication: 2024 Sep 07.
Autor:
Saugues S; Hématologie FBeirorlaongdiq, uFer,a nCcHe U Clermont-Ferrand, Clermont; Equipe d'Accueil EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand., Lambert C; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand., Daguenet E; Hématologie, Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez., Roth-Guepin G; Hématologie Clinique, CHRU Brabois, Vandoeuvre-les-Nancy., Huguet F; Hématologie, Institut Universitaire du Cancer Toulouse Oncopole, CHU de Toulouse, Toulouse., Cony-Makhoul P; Hématologie, CH Annecy-Genevois, Pringy., Ansah HJ; Institut d'Hématologie de Basse Normandie, CHU, Caen., Escoffre-Barbe M; Hématologie, Hôpital de Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes., Turhan A; Inserm U935 - Service d'Hématologie, Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre., Rousselot P; Hématologie Clinique, Centre Hospitalier de Versailles and UMR1184, Le Chesnay., Tchirkov A; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France; Cytogénétique Médicale, CHU Clermont-Ferrand, Clermont-Ferrand., Hamroun D; Direction de La Recherche Et de L'Innovation, CHRU de Montpellier, Montpellier., Hermet E; Hématologie Clinique Adulte, CHU Clermont-Ferrand, Clermont-Ferrand., Pereira B; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand., Berger MG; Hématologie FBeirorlaongdiq, uFer,a nCcHe U Clermont-Ferrand, Clermont; Equipe d'Accueil EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand, France; Hématologie Clinique Adulte, CHU Clermont-Ferrand, Clermont-Ferrand. mberger@chuclermontferrand.Fr.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 2893-2907. Date of Electronic Publication: 2024 Sep 01.